Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 22 results for "novartis india"

Novartis India announces next edition of BioCamp

BioCamp will be held in Hyderabad from July 6 to 8, 2015 Novartis Biotechnology Leadership Camp (BioCamp) will be held in Hyderabad from July 6 to 8, 2015. The BioCamp is a pioneering seminar organised by Novartis that brings talented students ... Financial Express, 13 hours ago

29 images for novartis india

Financial Express, 3 days ago
Chicago Daily Herald, 2 months ago
BDlive, 1 month ago
India Infoline, 2 months ago
FDA News, 1 month ago
India TV, 4 months ago
NDTV Profit, 4 months ago
Pharmaceutical Technology, 3 months ago
First, 3 months ago
Business Standard, 3 months ago
Financial Express

Bullish on India

Since 2013, Novartis has sharpened focus, with last April's asset swaps with GSK and Eli Lilly the next step in this process. In India, the Swiss company took a hit in April 2013 when the Supreme Court rejected its patent for its oncology drug ...
 Financial Express6 days ago

Good growth prospects despite headwinds

As we settle into FY2016, it is worth taking a quick look at some of the earning previews of the last quarter. An Edelweiss Q4FY15 result preview report on the pharmaceutical sector blames currency headwinds in emerging markets and more importantly, ...
 Financial Express6 days ago
Pharmaceutical Technology


GlaxoSmithKline Pharmaceuticals (GSK) will transfer its cancer drugs portfolio to an arm of Novartis India as part of a global deal between the two companies. In turn, GSK will acquire the vaccines division of Novartis .
 4 Traders2 months ago GSK completes $20bn three-part deal with Swiss Novartis  Pharmaceutical Technology1 month ago GSK Pharma to transfer cancer drug portfolio to Novartis arm  Business Standard2 months ago
India Infoline

Novartis India reports standalone net loss of Rs 1.18 crore in the December 2014 quarter

Sales decline 2.53% to Rs 213.02 crore Net loss of Novartis India reported to Rs 1.18 crore in the quarter ended December 2014 as against net profit of Rs 15.23 crore during the previous quarter ended December 2013. Sales declined 2.53% to Rs 213.02 crore in ...
 Business Standard2 months ago Novartis India slips 4%  India Infoline2 months ago Novartis India Q3 loss at Rs1.2 crore  India Infoline2 months ago Novartis Q3 net loss at Rs 1.18 crore  Business Standard2 months ago

Opportunity in the Indian Cardiovascular Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

FEATURED COMPANIES Aventis Pharma Limited Cipla Limited Lupin Limited Merck Limited Novartis India Limited Pfizer Limited MORE This report provides an insight into the ...
 Research and Markets1 month ago
IFSEC Global

Gunnebo India announces Sabyasachi Sengupta as New Country Manager and MD

Gunnebo India has appointed Sabyasachi Sengupta, formerly itsexecutive director of finance, as its new country manager and managing director. The newly promoted Sengupta has been associated with Gunnebo since 2008 and has been in the industry for ...
 IFSEC Global1 month ago Gunnebo India elevates senior executives  Security Today1 month ago Sabyasachi Sengupta is Country Manager for Gunnebo India  ChannelWorld India2 months ago

Shadow the Leader Program A BCCI Young Bombay Forum initiative, showcasing philanthropy through leadership

Previous story: Vistara launches services to Pune Next story: Mumbai : Young Bombay Forum, the youth wing of Bombay Chamber of Commerce and Industry today announced the launch of Shadow the Leader Program, an innovative and unique program for ...
 APN News2 weeks ago

IP Appellate Board upholds Wockhardt's petition for relief in diabetes drug patent row

The Intellectual Property Appellate Board (IPAB) on Wednesday ordered that Wockhardt need not produce any additional documents for evidence in a patent case against Novartis AG relating to an anti-diabetes drug. The Board upheld Wockhardt's ...
 Hindu Business Line1 month ago
Financial Express

Govt to release policy to improve bulk drug capacity: Subburaj

Other topics at the ASSOCHAM Pharma Summit included changes in drug pricing, the impending revision of NLEM-2011, and amendments in compensation guidelines and clinical trial approval process Dr VK Subbburaj, Secretary, Departmetn of ...
 Financial Express1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less